Overview
What is Targetcancer Foundation Inc?
Targetcancer Foundation Inc is a nonprofit organization situated in Cambridge, Massachusetts. Their primary focus is to advocate for and fund research into rare cancers, aiming to improve treatment options and patient support. In 2020, they launched the TCF-001 TRACK clinical trial, a 400-patient study on genomics and precision medicine in rare cancers. This initiative provides patients with personalized genomic data and treatment recommendations, while also generating valuable research data. In 2022, Targetcancer Foundation organized two significant scientific meetings, promoting collaboration and information-sharing among key stakeholders in the rare cancer field. With a small team of 4 employees, this organization is dedicated to advancing the fight against rare cancers.
Official website here: www.targetcancerfoundation.org
Is Targetcancer Foundation Inc legitimate?
Targetcancer Foundation Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Targetcancer Foundation Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $173,092
Professional Fundraising Fees: $0
Other Salaries and Wages: $98,239
For more financial information, click here
Official website here: www.targetcancerfoundation.org
What is the mission statement of Targetcancer Foundation Inc?
The Targetcancer Foundation Inc's mission is centered around promoting advancements in the treatment of rare cancers. They accomplish this by funding innovative research, fostering collaborations, and raising awareness among scientists, clinicians, and patients. The organization directly supports initiatives at the forefront of cancer treatment, including operating a rare cancer precision medicine clinical trial and launching a 400-patient study called TCF-001 TRACK. This trial provides patients with personalized genomic data and treatment recommendations, while also generating valuable research data on rare cancers. Moreover, Targetcancer Foundation organizes scientific meetings, such as the Think Tank on Advancing Precision Medicine in Rare Cancers and the Think Tank on Advancing Gastroesophageal Cancer Research, to promote collaboration, information-sharing, and idea generation within the field.
Official website here: www.targetcancerfoundation.org
Who is the CEO of Targetcancer Foundation Inc?
James Palma is the Director of Targetcancer Foundation Inc.
Official website here: www.targetcancerfoundation.org
What is the revenue of Targetcancer Foundation Inc?
Targetcancer Foundation Inc's revenue in 2023 was $846,106.
Official website here: www.targetcancerfoundation.org
Who are the executives of Targetcancer Foundation Inc and what are their salaries?
The average compensation at Targetcancer Foundation Inc during 2023 was $67,833. There are 4 employees and 30 volunteers at Targetcancer Foundation Inc.
Here are 11 key members and their salaries:
- James M Palma (Executive Director)
- Kristen Palma (President/Director)
- Jerry Alderman (Director)
- Jennifer Levin Carter Md (Director)
- Cj Chapman (Director)
- Samuel Davenport (Director)
- Janet Fine Ms (Director)
- Mary Pat Lancelotta (Director)
- Kristen Schuler Scammon (Director)
- Andrea Sullivan (Director)
- Colin Carey (Treasurer/Director)
Official website here: www.targetcancerfoundation.org
Where can I find the form 990 for Targetcancer Foundation Inc?
The Targetcancer Foundation Inc’s most recent form 990 was submitted in 2023 and can be accessed here
Official website here: www.targetcancerfoundation.org
Learn more at the official website: www.targetcancerfoundation.org
Mission Statement of Targetcancer Foundation Inc
Targetcancer Foundation Inc is committed to promoting the advancement of lifesaving treatment protocols for rare cancers. This nonprofit organization achieves its mission by directly supporting innovative research initiatives, fostering collaborations, and raising awareness among scientists, clinicians, and patients. The Foundation's primary objective is to fund projects that are at the forefront of cancer treatment, with a specific focus on rare cancers.
In pursuit of its mission, Targetcancer Foundation Inc launched the TCF-001 TRACK clinical trial in 2020. This 400-patient study investigates genomics and precision medicine in rare cancers, providing patients with critical genomic data about their cancer and tailored treatment recommendations from leading experts in the field. The trial also contributes to the generation of valuable research data on rare cancers. Additionally, the Foundation conducts scientific meetings, such as the Think Tank on Advancing Precision Medicine in Rare Cancers and the Think Tank on Advancing Gastroesophageal Cancer Research. These events bring together key stakeholders, including clinicians, researchers, government representatives, industry professionals, and patients and advocates, to promote collaboration, information-sharing, and idea generation. These initiatives aim to define research priorities, foster new collaborative efforts, and ultimately drive progress in the field of rare cancer treatment.
Impact
This information is meant to be a general summary of Targetcancer Foundation Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
TargetCancer Foundation Inc promotes the development of lifesaving treatment protocols for rare cancers. Through initiatives such as the rare cancer precision medicine clinical trial TRACK, the organization provides patients with personalized genomic data and treatment recommendations while generating valuable research data. Additionally, TargetCancer Foundation facilitates scientific meetings like the Think Tank on Advancing Precision Medicine in Rare Cancers and the Think Tank on Advancing Gastroesophageal Cancer Research, uniting key stakeholders to define research priorities and foster collaboration. This impactful work directly supports innovative research, fosters collaborations, and raises awareness among scientists, clinicians, and patients in the field of rare cancers.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2023.
- Assets and Liabilities:
Organization Details
Founding Year
2009
Phone
(617) 765-4881
Principal Officer
James Palma
Main Address
955 Massachusetts Avenue 343, Cambridge, MA, 02139
NTEE Category
Code: H30 - Medical research
If you are a representative of Targetcancer Foundation Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.